Havells India Limited (NSE:HAVELLS)
India · Delayed Price · Currency is INR 1,481.30
-7.40 (-0.50%)
Aug 7, 2025, 11:30 AM IST
Revance Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 14,723 | 12,708 | 10,717 | 11,965 | 10,443 | Upgrade |
Depreciation & Amortization | - | 3,916 | 3,306 | 2,887 | 2,525 | 2,415 | Upgrade |
Other Amortization | - | 88.1 | 79 | 74.7 | 83.6 | 74.6 | Upgrade |
Loss (Gain) From Sale of Assets | - | 151 | -102.7 | 1.4 | 14.3 | -403.9 | Upgrade |
Loss (Gain) From Sale of Investments | - | 90.3 | - | - | - | 11 | Upgrade |
Stock-Based Compensation | - | 104.5 | 42.6 | 17.7 | - | - | Upgrade |
Provision & Write-off of Bad Debts | - | 436.8 | 176.6 | 184.3 | 127.8 | 259.1 | Upgrade |
Other Operating Activities | - | -1,919 | -951.7 | -1,128 | -672.9 | 808.2 | Upgrade |
Change in Accounts Receivable | - | -1,094 | -1,934 | -2,115 | -2,088 | -3,319 | Upgrade |
Change in Inventory | - | -6,377 | 3,000 | -7,405 | -3,482 | -7,480 | Upgrade |
Change in Accounts Payable | - | 3,635 | 528.2 | 2,727 | 7,877 | 1,821 | Upgrade |
Change in Unearned Revenue | - | 58.4 | 193.2 | 292.3 | 75.7 | - | Upgrade |
Change in Other Net Operating Assets | - | 1,340 | 2,485 | -604.2 | 854.9 | 1,975 | Upgrade |
Operating Cash Flow | - | 15,153 | 19,529 | 5,649 | 17,280 | 6,603 | Upgrade |
Operating Cash Flow Growth | - | -22.41% | 245.68% | -67.31% | 161.69% | -20.13% | Upgrade |
Capital Expenditures | - | -7,660 | -7,861 | -5,878 | -2,583 | -2,499 | Upgrade |
Sale of Property, Plant & Equipment | - | 121.9 | 238 | 22.7 | 55.6 | 963.2 | Upgrade |
Investment in Securities | - | 1,802 | -10,371 | 5,004 | -6,051 | -7,296 | Upgrade |
Other Investing Activities | - | 2,720 | 1,855 | 1,201 | 993.3 | 1,204 | Upgrade |
Investing Cash Flow | - | -3,016 | -16,139 | 350.4 | -7,586 | -7,629 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 9,883 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 0.4 | 5,000 | Upgrade |
Total Debt Issued | - | - | - | - | 0.4 | 14,883 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -9,883 | Upgrade |
Long-Term Debt Repaid | - | -678.9 | -513.3 | -4,380 | -1,319 | -766.9 | Upgrade |
Total Debt Repaid | - | -678.9 | -513.3 | -4,380 | -1,319 | -10,649 | Upgrade |
Net Debt Issued (Repaid) | - | -678.9 | -513.3 | -4,380 | -1,319 | 4,233 | Upgrade |
Issuance of Common Stock | - | 425.4 | 213.2 | 266.7 | 311.5 | 98.2 | Upgrade |
Common Dividends Paid | - | -6,268 | -4,701 | -4,703 | -4,073 | -1,878 | Upgrade |
Other Financing Activities | - | -167 | -334.4 | -253.3 | -393.5 | -555.6 | Upgrade |
Financing Cash Flow | - | -6,689 | -5,336 | -9,069 | -5,473 | 1,898 | Upgrade |
Foreign Exchange Rate Adjustments | - | -37 | -45.4 | -37.3 | -9 | -3.3 | Upgrade |
Net Cash Flow | - | 5,412 | -1,991 | -3,107 | 4,212 | 869.2 | Upgrade |
Free Cash Flow | - | 7,493 | 11,668 | -228.5 | 14,697 | 4,104 | Upgrade |
Free Cash Flow Growth | - | -35.78% | - | - | 258.08% | -11.88% | Upgrade |
Free Cash Flow Margin | - | 3.44% | 6.28% | -0.14% | 10.54% | 3.92% | Upgrade |
Free Cash Flow Per Share | - | 11.95 | 18.62 | -0.36 | 23.47 | 6.56 | Upgrade |
Cash Interest Paid | - | 357.2 | 334.4 | 253.3 | 393.5 | 555.6 | Upgrade |
Cash Income Tax Paid | - | 5,055 | 3,919 | 3,919 | 4,149 | 2,727 | Upgrade |
Levered Free Cash Flow | - | 5,910 | 10,731 | -2,583 | 12,128 | 1,739 | Upgrade |
Unlevered Free Cash Flow | - | 6,134 | 10,941 | -2,409 | 12,423 | 2,167 | Upgrade |
Change in Net Working Capital | - | 1,599 | -5,746 | 7,891 | -2,748 | 6,174 | Upgrade |
Updated Jan 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.